Hy-Fv 6 X Liquid is a Health Canada–registered human drug (DIN 02233405) held by Botanical Laboratories Inc., containing Pulsatilla. Health Canada lists its status as Cancelled Post Market (status date 01 Jan 2006). Nexara Health has matched 7 registrations of Pulsatilla across 1 other regulated market, 3 of them in the same strength and dosage form.
Health Canada registration
| DIN | 02233405 |
|---|---|
| Brand name | Hy-Fv |
| Active ingredient | Pulsatilla |
| Strength | 6 X |
| Dosage form | Liquid |
| Route | Oral |
| Company | Botanical Laboratories Inc. |
| Status | Cancelled Post Market — 01 Jan 2006 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Pulsatilla registered in other markets
7 registrations of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| United States | Pulsatilla | Rxhomeo Private Limited d.b.a. Rxhomeo, Inc | Liquid | listed | FDA NDC | |
| United States | Pulsatilla 200C | Natural Creations, Inc | Liquid | listed | FDA NDC | |
| United States | Pulsatilla 7131 | Professional Complementary Health Formulas | Liquid | listed | FDA NDC | |
| United States | Pulsatilla | True Botanica, LLC | Globule | listed | FDA NDC | |
| United States | Pulsatilla | Historical Remedies | Pellet | listed | FDA NDC | |
| United States | Pulsatilla | Rxhomeo Private Limited d.b.a. Rxhomeo, Inc | Pellet | listed | FDA NDC | |
| United States | Pulsatilla 200ck | Sevene Usa | Pellet | listed | FDA NDC |
See every manufacturer of Pulsatilla worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Hy-Fv (DIN 02233405) marketed in Canada?
No. Health Canada lists DIN 02233405 as Cancelled Post Market as of 01 Jan 2006.
Who holds the Canadian licence for this product?
Botanical Laboratories Inc. is the company of record in the Health Canada Drug Product Database.
Is Pulsatilla registered outside Canada?
Yes — Nexara Health has matched 7 registrations in 1 other market, including 3 in the same strength and dosage form (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02233405, status date 2006-01-01; national medicine registries: FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02233405, status date 2006-01-01; national medicine registries: FDA NDC.
Health Canada Drug Product Database (DPD), DIN 02233405, status date 2006-01-01; national medicine registries: FDA NDC. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.